top of page
iPharmaCenter
ipharmacenter Consulting services
ipharmacenter
Consulting services
ipharmacenter
Consulting services
ipharmacenter
Consulting services
Home
Pharma
US FDA Approvals
North America
China Drug Approvals
Japan Drug Approvals | Healthcare
India Drug Approvals
APAC - Drug Approvals
LACAM
Europe
Canada Drug Healthcare News
Brazil - Drug approvals
EMA News
APAC
Therapy News
Immunology
Neurology
Oncology
Kidney Diseases
Cardiovascular
Infections_Vaccines
Metabolic Diseases
Women Health
Healthcare News
US Healthcare News
US Payer News
Europe Healthcare News
NICE Assessment Outcomes
G-BA Assessment Outcomes
APAC - Healthcare News
Lacam Healthcare News
Healthcare Policies
Conferences
All News
For sponsored articles, link insertions, and advertisements, please write to
info@ipharmacenter.com
Respiratory syncytial virus | News | Updates | iPharmaCenter
ExpressScripts is optimistic about the RSV season with the approval of new vaccines In May 2023, the U.S. Food & Drug Administration...
HPV News | Updates | iPharmaCenter
Merck has released a comprehensive publication on the long-term follow-up (LTFU) data for Gardasil 9 (Human Papillomavirus 9-valent...
Meningococcal infection | iPharmaCenter
GlaxoSmithKline (GSK) has presented positive results from the phase III trial of its MenABCWY vaccine candidate at the European Society...
HIV News and media blogs | Viiv's Apretude approved in the US for HIV prevention
Janssen to discontinue HIV vaccine Phase 3 trial. Janssen Pharmaceuticals and Global Partners announced their intention to discontinue...
bottom of page